GULP1, a multifaceted diagnostic biomarker and potential therapeutic target in hepatocellular carcinoma: Editorial on "GULP1 as a novel diagnostic and predictive biomarker in hepatocellular carcinoma"

Affiliations

Editorial

Yuhao Xie et al. Clin Mol Hepatol. 2026 Jan.

. 2026 Jan;32(1):413-415.

doi: 10.3350/cmh.2025.0315. Epub 2025 Mar 24.

¹ Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St John's University, Queens, NY, USA.

No abstract available

Keywords: Beta catenin; Biomarker; GULP1 protein; Hepatocellular carcinoma.

Conflict of interest statement

Conflicts of Interest

The authors have no conflicts to disclose.

GULP1 as a novel diagnostic and predictive biomarker in hepatocellular carcinoma.
Kim HS, Yoon JH, Choi JY, Yoon MG, Baek GO, Kang M, Jang SH, Park W, Go Y, Ng JT, Nam SW, Jeong JY, Han JE, Cho HJ, Lim SB, Kim SS, Cheong JY, Eun JW. Kim HS, et al. Clin Mol Hepatol. 2025 Jul;31(3):914-934. doi: 10.3350/cmh.2024.1038. Epub 2025 Feb 6. Clin Mol Hepatol. 2025. PMID: 39914372 Free PMC article.

1. Cao LQ, Xie Y, Fleishman JS, Liu X, Chen ZS. Hepatocellular carcinoma and lipid metabolism: Novel targets and therapeutic strategies. Cancer Lett. 2024;597:217061. - PubMed
1. Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391:1301–1314. - PubMed
1. Yang X, Yang C, Zhang S, Geng H, Zhu AX, Bernards R, et al. Precision treatment in advanced hepatocellular carcinoma. Cancer Cell. 2024;42:180–197. - PubMed
1. Johnson P, Zhou Q, Dao DY, Lo YMD. Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2022;19:670–681. - PubMed
1. Kim HS, Yoon JH, Choi JY, Yoon MG, Baek GO, Kang M, et al. GULP1 as a novel diagnostic and predictive biomarker in hepatocellular carcinoma. Clin Mol Hepatol. 2025;31:914–934. - PMC - PubMed